Grants and Contributions

The Centre for Research on Pandemic Preparedness and Health Emergencies (CRPPHE) is housed at CIHR with a mandate to grow Canada’s research leadership in preparedness, prevention, response, and recovery from pandemics and public health emergencies, including by building and supporting Canadian research capacity in the field. For more information about it’s mandate and objectives visit the CRPPHE website: https://cihr-irsc.gc.ca/e/52397.html

The Centre for Research on Pandemic Preparedness and Health Emergencies (CRPPHE) is housed at CIHR with a mandate to grow Canada’s research leadership in preparedness, prevention, response, and recovery from pandemics and public health emergencies, including by building and supporting Canadian research capacity in the field. For more information about it’s mandate and objectives visit the CRPPHE website: https://cihr-irsc.gc.ca/e/52397.html

• The CIHR HIV/AIDS and STBBI Research Initiative (RI), under the leadership of the CIHR Institute of Infection and Immunity (CIHR-III), is responsible for funding research on human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR research themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research.
• Research that focuses on key populations disproportionately affected by HIV/AIDS and STBBI is highly encouraged.
• In alignment with CIHR's commitment to equity, diversity and inclusion (EDI) in the research system, the RI champions EDI as a means to support excellence in research, training and knowledge mobilization. Therefore, we encourage people from diverse backgrounds, including groups underrepresented in science such as women and racial and ethnic minorities, to apply.
• This priority announcement will prioritize funding for research on HIV and/or STBBI aligned with the CIHR HIV/AIDS Research Initiative: Strategic Plan (2022-2027) in the following research areas:
o Improving health equity by advancing research to understand and address determinants of health, new models of care, or sexual and reproductive health for people living with or at risk of HIV/AIDS and STBBI; or
o Accelerating discovery and innovation by advancing research on innovative technologies for testing and surveillance, interactions among infections and co-morbidities, or design and development of next-generation interventions.
• Should there be no eligible applications relevant to the research areas identified above, applications must be in alignment with the strategic directions of the CIHR HIV/AIDS Research Initiative: Strategic Plan (2022-2027) to be funded.

• The CIHR HIV/AIDS and STBBI Research Initiative (RI), under the leadership of the CIHR Institute of Infection and Immunity (CIHR-III), is responsible for funding research on human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR research themes: biomedical research, clinical research, health services research and social, cultural, environmental and population health research.
• Research that focuses on key populations disproportionately affected by HIV/AIDS and STBBI is highly encouraged.
• In alignment with CIHR's commitment to equity, diversity and inclusion (EDI) in the research system, the RI champions EDI as a means to support excellence in research, training and knowledge mobilization. Therefore, we encourage people from diverse backgrounds, including groups underrepresented in science such as women and racial and ethnic minorities, to apply.
• This priority announcement will prioritize funding for research on HIV and/or STBBI aligned with the CIHR HIV/AIDS Research Initiative: Strategic Plan (2022-2027) in the following research areas:
o Improving health equity by advancing research to understand and address determinants of health, new models of care, or sexual and reproductive health for people living with or at risk of HIV/AIDS and STBBI; or
o Accelerating discovery and innovation by advancing research on innovative technologies for testing and surveillance, interactions among infections and co-morbidities, or design and development of next-generation interventions.
• Should there be no eligible applications relevant to the research areas identified above, applications must be in alignment with the strategic directions of the CIHR HIV/AIDS Research Initiative: Strategic Plan (2022-2027) to be funded.

This award is intended to honor the outstanding work and trailblazing innovations of Dr. Robyn Tamblyn, the former Scientific Director of the CIHR Institute of Health Services and Policy Research (CIHR-IHSPR).

To recognize the excellence of research and innovation in health services and policy research being conducted in Canada, a prize of $25,000 will be given to the highest ranked mid-career investigator in the Project Grant competition whose project is relevant to CIHR-IHSPR’s mandate.

This prize is a supplemental grant to support research and/or knowledge mobilization and has to be used according to the CIHR Application Administration Guide. The prize is non-renewable.

• This award was established to recognize the excellence of the health services and policy researchers at an early stage in their career. This award will be given to the highest ranking Early-Career Researcher (ECR) in the Project Grant competition whose project is relevant to the mandate of CIHR’s Institute of Health Services and Policy Research (CIHR-IHSPR).
• This award is a supplemental grant to support research and/or knowledge mobilization and has to be used according to the CIHR Application Administration Guide. The prize is non-renewable.

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined relevant to its mandate and research priority areas as described below:
• IMHA mandate areas
o Pain
o Oral Health

• The CIHR Institute for Population and Public Health (CIHR-IPPH) will fund applications that are relevant to their mandate, focused on improving equitable health outcomes and aligned with one of the following priority areas identified in Transforming Public Health: IPPH Strategic Plan 2022-2026:
o Healthy Cities: IPPH will support proposals that are aligned with CIHR’s Healthy Cities Research Initiative (HCRI) and are focused on population health intervention research and/or implementation science as it relates to urban environments.
o Equity Science: IPPH will support proposals that advance the development and use of community-led and community-based data driven approaches for health solutions addressing experiences of disadvantage and discrimination.
o Public Health Systems: IPPH will support proposals that aim to identify and/or address key public health systems research priorities in Canada.

• The CIHR Institute for Population and Public Health (CIHR-IPPH) will fund applications that are relevant to their mandate, focused on improving equitable health outcomes and aligned with one of the following priority areas identified in Transforming Public Health: IPPH Strategic Plan 2022-2026:
o Healthy Cities: IPPH will support proposals that are aligned with CIHR’s Healthy Cities Research Initiative (HCRI) and are focused on population health intervention research and/or implementation science as it relates to urban environments.
o Equity Science: IPPH will support proposals that advance the development and use of community-led and community-based data driven approaches for health solutions addressing experiences of disadvantage and discrimination.
o Public Health Systems: IPPH will support proposals that aim to identify and/or address key public health systems research priorities in Canada.

Patient-Oriented Research (POR), which is foundational to evidence-informed health care, refers to a continuum of research that engages patients, including People with Lived and Living Experience (PWLLE), as partners throughout the research process, focusses on patient-identified priorities, and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve health outcomes for Canadians.

The Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, health authorities, academic health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of patient-oriented research into care.

SPOR funded research requires the inclusion of a diversity of patients (including PWLLE) in health research in a culturally safe manner, while considering accessibility and equity within the patient partners they include in their patient-oriented research.

The vision for SPOR is that Canada will demonstrably improve health outcomes and enhance the health care experience for patients through the integration of evidence at all levels of the health care system.